Experimental models of spontaneous autoimmune disease in the central nervous system

G Krishnamoorthy, A Holz, H Wekerle - Journal of Molecular Medicine, 2007 - Springer
G Krishnamoorthy, A Holz, H Wekerle
Journal of Molecular Medicine, 2007Springer
Animal models have become essential tools for studying the human autoimmune disease.
They are of vital importance in explorations of disease aspects, where, for diverse reasons,
human material is unavailable. This is especially true for disease processes preceding
clinical diagnosis and for tissues, which are inaccessible to routine biopsy. Early developing
multiple sclerosis (MS) makes an excellent point in case for these limitations. Useful disease
models should be developing spontaneously, without a need of artificial, adjuvant-supported …
Abstract
Animal models have become essential tools for studying the human autoimmune disease. They are of vital importance in explorations of disease aspects, where, for diverse reasons, human material is unavailable. This is especially true for disease processes preceding clinical diagnosis and for tissues, which are inaccessible to routine biopsy. Early developing multiple sclerosis (MS) makes an excellent point in case for these limitations. Useful disease models should be developing spontaneously, without a need of artificial, adjuvant-supported induction protocols, and they should reflect credibly at least some of the complex features of human disease. The aim of this review is to compile models that exhibit spontaneous organ-specific autoimmunity and explore their use for studying MS. We first evaluate a few naturally occurring models of organ-specific autoimmune diseases and then screen autoimmunity in animals with compromised immune regulation (neonatal thymectomy, transgenesis, etc.). While most of these models affect organs other than the nervous tissues, central nervous system (CNS)-specific autoimmune disease is readily noted either after transgenic overexpression of cytokines or chemokines within the CNS or by introducing CNS-specific immune receptors into the lymphocyte repertoire. Most recently, spontaneous autoimmunity resembling MS was obtained by transgenic expression of self-reactive T cell receptors and B cell receptors. These transgenic models are not only of promise for studying directly disease processes during the entire course of the disease but may also be helpful in drug discovery.
Springer